Development of a scaffold displaying exoloops of RXFP1 Natalie A. Diepenhorst, Paul R. Gooley, Martin J. Stone, Ross A.D. Bathgate 1-3 PDF
Recombinant RXFP1-LDL-A module does not form dimers Emma J. Petrie, Matthew A. Periguini, Ross A.D. Bathgate, Paul R. Gooley 4 -6 PDF
Cell-free protein synthesis as a tool to study RXFP3- Relaxin-3 protein interactions Patrick J. Shilling, Ross A.D. Bathgate, Paul R. Gooley 7-9 PDF
Development of human cells with RXFP1 knockdown using retroviral delivery of microRNA against human RXFP1 K.J. Yong, G.E. Callander, R. Bergin, C.S. Samuel, R.A.D Bathgate 10-12 PDF
A total solid-phase synthesis of DILP8 Sabirov Aydar, Lyu Rong-Ming, Chen Xiang-Qun, Tian Qing, Chang Jaw-Kang 13-14 PDF
Expression and localization of RLF/ INSL3 receptor RXFP2 in boar testes Tetsuya Kohsaka, Dai Sagata, Itaru Minagawa, Hiroshi Kohriki, Ali Mohammed Pitia, Yusuke Sugii, Masashi Morimoto, Naoto Uera, Masatoshi Shibata, Hiroshi Sasada, Yoshihisa Hasegawa 23-25 PDF
Relaxin and Sertoli cell proliferation Aline R. Nascimento, Maristela T. Pimenta, Thais F.G. Lucas, Catarina S. Porto, Maria F.M. Lazari 26-28 PDF
Effects of relaxin in a co-culture of Sertoli and germ cells Catarina S. Porto, Catarina S. Porto, Maria F.M. Lazari 29-31 PDF
Mechanisms of INSL3 signaling in male reproductive organs Zaohua Huang, Elena M. Kaftanovskaya, Bryan Rivas, Alexander I. Agoulnik 32-33 PDF
Plasma insulin-like factor 3 (INSL3) in male patients with osteoporosis and Klinefelter’s syndrome Andleeb Hussain, Ramasamyiyer Swaminathan, Arun Sankaralingam, Paul V. Carroll, Geeta Hampson, Barbara M. McGowan 34-36 PDF
Consequences of relaxin-3 null mutation in mice on food-entrainable arousal Ihaia T. Hosken, Craig M. Smith, Berenice E. Chua, Andrew L. Gundlach 37-41 PDF
Viral-mediated delivery of an RXFP3 agonist into brain promotes arousal in mice Craig M. Smith, Anna Blasiak, Despina E. Ganella, Berenice E. Chua, Sharon L. Layfield, Ross A.D. Bathgate, Andrew L. Gundlach 42-46 PDF
Potential hypothalamic targets of relaxin-3 innervation: a perspective Craig M. Smith, Berenice E. Chua, Andrew W. Walker, Andrew L. Gundlach 47-51 PDF
Pharmacological activation of RXFP3 is not orexigenic in C57BL/6J mice Craig M. Smith, Ihaia T. Hosken, Natalie L. Downer, Berenice E. Chua, Mohammad Akhter Hossain, John D. Wade, Andrew L. Gundlach 52-55 PDF
Behavioral analysis of relaxin-3 deficient mice Masaki Tanaka, Eriko Furube, Miku Aoki, Yoshihisa Watanabe 56-59 PDF
Anti-arthritic actions of relaxin, in combination with estrogens, in joint and bone tissue Carol A. Bagnell, Karen Santora, Teh-Yuan Ho 60-61 PDF
Mechanisms for Relaxin’s Modulation of MMPs and Matrix Loss in Fibrocartilages Sunil Kapila, Young Park, Nisar Ahmad, Jun Hosomichi, Takayuki Hayami, Claire Tacon 62-65 PDF
Porcine derived relaxin stimulates new vessel formation and improves the disturbed wound healing of the genetically diabetic mice Francesco Squadrito, Alessandra Bitto, Natasha Irrera, Letteria Minutoli, Paolo Caccia, Domenica Altavilla 66-70 PDF
In vitro model based on human keratinocyte to evaluate relaxin activity on wound healing exploiting time-lapse video microscopy Antonietta Stellavato, Donatella Cimini, Rosario Finamore, Katia Della Corte, Gilda Fiandra, Mario De Rosa, Chiara Schiraldi 71-73 PDF
Acute treatment with relaxin attenuates the injury/ dysfunction induced by renal ischemia/reperfusion injury Massimo Collino, Mara Rogazzo, Alessandro Pini, Elisa Benetti, Arianna Carolina Rosa, Roberto Fantozzi, Daniele Bani, Emanuela Masini 74-76 PDF
Relaxin, cardiac stem cells and heart regeneration Lucia Silvia, Silvia Nistri, Chiara Sassoli, Daniele Bani 77-79 PDF
Muscular effects of relaxin on the mouse colon: mechanical and electrophysiological studies Roberta Squecco, Rachele Garella, Fabio Francini, Maria C. Baccari 82-83 PDF
Efficacy and safety of oral porcine relaxin (pRLX) in adjunct to physical exercise in the treatment of peripheral arterial disease (PAD) Francesco Sonaglia, Paolo Milia, Marco Caserio, Bernardo Bigazzi, Benedetta Bigazzi, Serena Ricotta, Daniele Bani, Mario Bigazzi 84-91 PDF
Efficacy of Relaxin on functional recovery of post stroke patients Paolo Milia, Marco Caserio, Daniele Bani, Tito Filippo Rastelli, Francesco Sonaglia, Bernardo Bigazzi, Mario Bigazzi 92-97 PDF
Modifications in relaxin’s serum levels during acetatefree biofiltration (AFB): only a new biomarker? Valeria Cernaro, Antonio Lacquaniti, Grazia Giorgianni, Davide Bolignano, Michele Buemi 98-99 PDF
